FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to analogs of prostaglandin of the formula (I): , wherein A means -CH2-CH2- or -CH=CH-; B is absent or means phenyl; Z means -C(O)OR' or tetrazole-5-yl wherein R' means hydrogen atom or (C1-C6)-alkyl; m = 1, 2, 3, 4, 5 or 6; R1 means (C1-C6)-alkyl, unsubstituted phenyl or phenyl substituted with at least one substitute chosen from the group comprising trifluoromethyl, halogen atom, -Y-Ra, -Y-ORa and -Y-C(O)Ra wherein Y means chemical bond or (C1-C3)-alkylene group; Ra means (C1-C6)-alkyl, unsubstituted phenyl or phenyl substituted with at least one substitute chosen from the group comprising (C1-C6)-alkyl, (C1-C6)-alkoxy-group, trifluoromethyl and halogen atom under condition that B means phenyl and R3, R4, R5 and R6 do not mean hydrogen atom simultaneously; or R1 means unsubstituted phenyl or phenyl substituted with at least one substitute chosen from the group comprising trifluoromethyl, -Y-Ra, -Y-ORa and -Y-C(O)Ra wherein Y means chemical bond or (C1-C)-alkylene group; Ra means (C1-C6)-alkyl, unsubstituted phenyl or phenyl substituted with at least one substitute chosen from the group comprising (C1-C6)-alkyl, (C1-C6)-alkoxy-group, trifluoromethyl and halogen atom under condition that B is absent and R3, R4, R5 and R6 means hydrogen atom simultaneously; R2 means hydrogen atom; each among R3, R4, R5 and R6 means independently of one another hydrogen atom or (C1-C6)-alkyl, or its pharmaceutically acceptable salt or individual isomer. Compounds of the formula (1) possess a selective agonistic activity with respect to ER4-receptors and therefore they can be used in pharmaceutical composition.
EFFECT: improved method of synthesis, valuable medicinal properties of compounds and pharmaceutical composition.
22 cl, 2 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 2-PYRROLIDONE AS PROSTANOID AGONISTS AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2296122C2 |
DERIVATIVES OF 2-PIPERIDONE AS PROSTAGLANDIN AGONISTS | 2004 |
|
RU2311409C2 |
CARBOXAMIDE COMPOUNDS AND USING THEM AS CALPAIN INHIBITORS | 2010 |
|
RU2540856C2 |
COMPOUNDS FOR TREATING COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2703995C2 |
NEW TRIARYLIMIDAZOLES | 2004 |
|
RU2372346C2 |
NOVEL 1H-INDOLE-3-ACETAMIDES AS INHIBITORS OF SPLA AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2162463C2 |
BIFUNCTIONAL CYTOTOXIC AGENTS | 2015 |
|
RU2669807C2 |
DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS | 2001 |
|
RU2267490C2 |
SUBSTITUTED GAMMA-LACTAMS AS THERAPEUTIC AGENTS | 2006 |
|
RU2412933C2 |
HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S TRANSPORTATION INHIBITORS | 2005 |
|
RU2424239C2 |
Authors
Dates
2006-12-10—Published
2002-07-08—Filed